GlassScriptPhysician profile
Nikki L Behner
NPI 1548472244
$8,993.21
in general payments reported to CMS, 2019-2025
16 companies · $1,534 in 2025
The $1,534 reported for 2025 was more than what 88% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,367 · 2022: $1,462 · 2023: $2,150 · 2024: $2,480 · 2025: $1,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,917 · Education: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,916.87 |
| Education | $247.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,817.27 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $1,508.13 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Teva Pharmaceuticals USA, INC. | $1,196.83 | 2021-2025 | Austedo Xr, Uzedy, Austedo |
| Abbvie INC. | $1,060.59 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $758.42 | 2021-2025 | Ingrezza |
| Alkermes, INC. | $739.38 | 2021-2025 | Aristada, Lybalvi |
| Axsome Therapeutics, INC. | $636.17 | 2022-2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $423.53 | 2024-2025 | Cobenfy |
| Janssen Pharmaceuticals, INC | $421.10 | 2021-2025 | Invega Sustenna, Invega, Invega Trinza |
| Lundbeck LLC | $164.05 | 2021-2024 | Rexulti |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $156.29 | 2022-2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $50.52 | 2022-2025 | Fanapt |
| Indivior INC. | $20.10 | 2023 | Perseris |
| Johnson & Johnson Surgical Vision, INC. | $16.60 | 2021 | |
| Merck Sharp & Dohme LLC | $12.49 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikki Behner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.